By the same reasoning, it appears that a p53 mutation is required for BRCA1-related breast cancer development because otherwise, chromosoml aberrations due to BRCA1 deficiency would activate p53, leading to cell cycle arrest, apoptosis, and/or senescence of the tumor cells. Here, TP53 is linked to breast cancer.